Meetings: Musculoskeletal disorders prevention; national occupational research agenda development,

[Federal Register: February 11, 1999 (Volume 64, Number 28)]

[Notices]

[Page 6905]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr11fe99-73]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC); Meeting.

Name: Meeting to discuss ``Developing a National Occupational Research Agenda for Prevention of Musculoskeletal Disorders.''

Time and Date: 9 a.m.-4:30 p.m., March 8, 1999.

Place: Houston Marriott Westside, 13210 Katy Freeway, Houston, TX 77079. Telephone 281/558-8338.

Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 70 people. Seating will be limited to approximately 50 people.

Purpose: To request public assistance in identifying research gaps in the area of work-related musculoskeletal disorders. NIOSH and its partners are developing a plan to establish a National Occupational Research Agenda on work-related musculoskeletal disorders. The working team includes members from NIOSH, other government agencies, industries, and academia. In order to obtain maximum input from practitioners, academic and corporate researchers, and organizations sponsoring research, the team adopted a multi-phase approach for seeking input on the national research agenda. The first phase, which has recently been completed, involved three public meetings with industrial practitioners and was performed in Chicago, Seattle, and Washington, D.C. The meetings included representatives from diverse industry sectors, including light and heavy manufacturing; warehouse and transportation; office environments; acute and long-term health care; forest products; construction and maritime; and agriculture and food processing. A list of research gaps was identified. The working team is moving into the second phase and is seeking individual input from academicians, researchers, and others on which research gaps could be completed within five years and if any gaps have been missed.

Contacts for More Information: Thomas Waters, Ph.D., NIOSH, CDC, M/ S P03/C24, 4676 Columbia Parkway, Cincinnati, OH 45226. Telephone 513/ 533-8510. Hongwei Hsiao, Ph.D., NIOSH, CDC, M/S P119, 1095 Willowdale Road, Morgantown, WV 26505. Telephone 304/285-5910.

The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: February 5, 1999. Carolyn J. Russell, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).

[FR Doc. 99-3347Filed2-10-99; 8:45 am]

BILLING CODE 4160-19-P